1.33
Schlusskurs vom Vortag:
$1.39
Offen:
$1.41
24-Stunden-Volumen:
68,160
Relative Volume:
0.09
Marktkapitalisierung:
$7.73M
Einnahmen:
$3,000
Nettoeinkommen (Verlust:
$-8.79M
KGV:
-0.6323
EPS:
-2.1033
Netto-Cashflow:
$-8.46M
1W Leistung:
-2.92%
1M Leistung:
-2.21%
6M Leistung:
-50.37%
1J Leistung:
-44.12%
Biocardia Inc Stock (BCDA) Company Profile
Firmenname
Biocardia Inc
Sektor
Branche
Telefon
650-226-0123
Adresse
320 SOQUEL WAY, SUNNYVALE, CA
Vergleichen Sie BCDA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 0.41 | 0 | 0 | 0 | 0 | 0.00 | |
|
MOBBW
Mobilicom Limited Warrants
|
2.50 | 4.21B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
19.99 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
4.825 | 217.47M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.2288 | 502.27M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.3695 | 0 | 0 | 0 | 0 | 0.00 |
Biocardia Inc Stock (BCDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-04-16 | Herabstufung | Dawson James | Buy → Neutral |
Biocardia Inc Aktie (BCDA) Neueste Nachrichten
How strong dollar benefits BioCardia Inc. (6JU0) stockPortfolio Gains Summary & Low Risk High Win Rate Picks - newser.com
Is BioCardia Inc. forming a bottoming base2025 Year in Review & Weekly Watchlist for Consistent Profits - newser.com
Price action breakdown for BioCardia Inc.Gold Moves & Fast Exit and Entry Strategy Plans - newser.com
How institutional ownership impacts BioCardia Inc. stockJuly 2025 News Drivers & Risk Adjusted Swing Trade Ideas - newser.com
Why BioCardia Inc. (6JU0) stock appears on watchlistsGap Up & Daily Oversold Bounce Ideas - newser.com
Applying sector rotation models to BioCardia Inc.July 2025 Movers & Comprehensive Market Scan Insights - newser.com
Using flow based indicators on BioCardia Inc.2025 Market Sentiment & Fast Entry High Yield Tips - newser.com
Custom watchlist performance reports with BioCardia Inc.2025 Major Catalysts & Target Return Focused Picks - newser.com
How BioCardia Inc. (6JU0) stock responds to job market shiftsEarnings Trend Report & Daily Market Momentum Tracking - newser.com
Can BioCardia Inc. stock sustain institutional interestJuly 2025 Selloffs & Free Real-Time Volume Trigger Notifications - newser.com
What catalysts could drive BioCardia Inc. stock higher2025 Big Picture & Technical Entry and Exit Alerts - newser.com
Why BioCardia Inc. stock could benefit from AI revolutionJuly 2025 Gainers & Capital Protection Trading Alerts - newser.com
Can BioCardia Inc. (6JU0) stock sustain free cash flow2025 Volatility Report & AI Powered Trade Plan Recommendations - newser.com
Will BioCardia Inc. (6JU0) stock return to pre crash levelsMarket Weekly Review & Low Drawdown Trading Techniques - newser.com
Can BioCardia Inc. stock hit record highs againWeekly Trade Review & Weekly Watchlist for Hot Stocks - newser.com
How to forecast BioCardia Inc. trends using time seriesQuarterly Profit Review & Reliable Price Action Trade Plans - newser.com
What to expect from BioCardia Inc. in the next 30 daysTrade Performance Summary & Long-Term Capital Growth Strategies - newser.com
Is BioCardia Inc. stock positioned for digital transformationJuly 2025 Fed Impact & Weekly High Return Stock Forecasts - newser.com
BioCardia’s CardiAMP HF II Phase 3 Trial Reaches Milestone With First Patient Enrollment At University Of Wisconsin - Pulse 2.0
Smart tools for monitoring BioCardia Inc.’s price actionQuarterly Trade Report & Safe Entry Momentum Tips - newser.com
Measuring BioCardia Inc.’s beta against major indicesMarket Activity Recap & Daily Technical Forecast Reports - newser.com
What is the fair value estimate for BioCardia Inc. (6JU0) stock in 2025Day Trade & Real-Time Price Movement Reports - newser.com
BioCardia, Inc. (BCDA) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
BioCardia enrolls first patient at UW in phase 3 heart failure trial - Investing.com Canada
BioCardia enrolls first patient at UW in phase 3 heart failure trial By Investing.com - Investing.com South Africa
BioCardia Advances Phase 3 CardiAMP HF II Trial - TipRanks
Finanzdaten der Biocardia Inc-Aktie (BCDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):